Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. March 11, 2019. Scott Gottlieb.

Executive Summary

Outgoing US FDA Commissioner Scott Gottlieb does not want the agency hierarchy shook up once he departs, preferring "to keep the FDA team intact." See what else he said here.

"In terms of a nominee, that's obviously a longer process and I don't think that they're at the point of making decisions around that yet. But I think in terms of who steps in to fill the role in an acting capacity there's some good names in the mix. I feel good about it and I feel good about the people who are going to stay behind." –Scott Gottlieb, commissioner, US FDA

Click here for a free trial of Medtech Insight


Related Content

Gottlieb Wants His US FDA Team To Stay Together After He Departs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts